Stereotaxis Innovates Heart Procedures With Robotic Magnetic Navigation

January 21, 2020

David Fischel, Chairman and CEO of Stereotaxis, discusses RMN innovation in the treatment of some heart conditions.

WATCH NEXT

Quibi Set High Expectations but Failed on Execution, Say Marketing Execs

Oct 8, 2020

7:28

MindMed Invests $5 Million in NYU Langone for Psychedelic Research Center

Psychedelic medicine company MindMed is investing $5 million in a new research center. J.R Rahn, co-founder and co-CEO of MindMed, discusses the investment and plans to hit the markets.

Oct 19, 2020

Billionaires Hit Peak of $10 Trillion as Rich Get Richer Amid COVID

A report, titled "Riding the Storm," provides one of the most comprehensive cross-sections of the billionaire class amid a tumultuous year.

Oct 12, 2020

6:23

Mental Health Telemedicine Company Cerebral Completes $35 Million Series A Funding Round

The coronavirus pandemic has placed telemedicine at the forefront of the health care industry. To highlight that point, the mental health telemedicine company Cerebral recently turned heads with a $35 million Series A funding round, just nine months after launching. We welcome in Cerebral co-founder and CEO Kyle Robertson to tell us more about his company, and how it's changing the mental health space for the better.

We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.

Stereotaxis Innovates Heart Procedures With Robotic Magnetic Navigation

Related